235 related articles for article (PubMed ID: 33246937)
21. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
Gebbia V; Testa A; Gebbia N
Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133
[TBL] [Abstract][Full Text] [Related]
22. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide.
Wen HS; Li X; Cao YZ; Zhang CC; Yang F; Shi YM; Peng LM
Chemotherapy; 2012; 58(6):461-7. PubMed ID: 23406994
[TBL] [Abstract][Full Text] [Related]
23. Management of cancer cachexia.
Bozzetti F
Tumori; 2014; 100(1):e1. PubMed ID: 24675503
[No Abstract] [Full Text] [Related]
24. Management of cancer cachexia (reply).
Kanat O
Tumori; 2014; 100(1):e1. PubMed ID: 24675504
[No Abstract] [Full Text] [Related]
25. Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection.
Von Roenn JH; Murphy RL; Wegener N
Semin Oncol; 1990 Dec; 17(6 Suppl 9):13-6. PubMed ID: 2259923
[TBL] [Abstract][Full Text] [Related]
26. Megestrol acetate in patients with AIDS-related cachexia.
Von Roenn JH; Armstrong D; Kotler DP; Cohn DL; Klimas NG; Tchekmedyian NS; Cone L; Brennan PJ; Weitzman SA
Ann Intern Med; 1994 Sep; 121(6):393-9. PubMed ID: 7794302
[TBL] [Abstract][Full Text] [Related]
27. Megestrol acetate NCD oral suspension -- Par Pharmaceutical: megestrol acetate nanocrystal dispersion oral suspension, PAR 100.2, PAR-100.2.
Drugs R D; 2007; 8(4):251-4. PubMed ID: 17596111
[TBL] [Abstract][Full Text] [Related]
28. Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta-analysis.
Simon L; Baldwin C; Kalea AZ; Slee A
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):23-41. PubMed ID: 34881518
[TBL] [Abstract][Full Text] [Related]
29. [Current views on use of megestrol acetate in oncology practice].
Vyzula R
Vnitr Lek; 1997 Apr; 43(4):250-5. PubMed ID: 9601846
[TBL] [Abstract][Full Text] [Related]
30. Management of cancer anorexia/cachexia.
Loprinzi CL
Support Care Cancer; 1995 Mar; 3(2):120-2. PubMed ID: 7773579
[TBL] [Abstract][Full Text] [Related]
31. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.
Maltoni M; Nanni O; Scarpi E; Rossi D; Serra P; Amadori D
Ann Oncol; 2001 Mar; 12(3):289-300. PubMed ID: 11332139
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.
Cuvelier GD; Baker TJ; Peddie EF; Casey LM; Lambert PJ; Distefano DS; Wardle MG; Mychajlunow BA; Romanick MA; Dix DB; Wilson BA
Pediatr Blood Cancer; 2014 Apr; 61(4):672-9. PubMed ID: 24167059
[TBL] [Abstract][Full Text] [Related]
33. Progesterone therapy for the treatment of non-cancer cachexia: a systematic review.
Taylor JK; Pendleton N
BMJ Support Palliat Care; 2016 Sep; 6(3):276-86. PubMed ID: 27098973
[TBL] [Abstract][Full Text] [Related]
34. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J
Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858
[TBL] [Abstract][Full Text] [Related]
35. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review).
Strang P
Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597
[TBL] [Abstract][Full Text] [Related]
36. Comparison of three different treatment modalities in the management of cancer cachexia.
Kanat O; Cubukcu E; Avci N; Budak F; Ercan I; Canhoroz M; Olmez F
Tumori; 2013; 99(2):229-33. PubMed ID: 23748819
[TBL] [Abstract][Full Text] [Related]
37. Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
Loprinzi CL; Bernath AM; Schaid DJ; Malliard JA; Athmann LM; Michalak JC; Tschetter LK; Hatfield AK; Morton RF
Oncology; 1994 Oct; 51 Suppl 1():2-7. PubMed ID: 7970505
[TBL] [Abstract][Full Text] [Related]
38. Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study.
Yeh SS; Wu SY; Lee TP; Olson JS; Stevens MR; Dixon T; Porcelli RJ; Schuster MW
J Am Geriatr Soc; 2000 May; 48(5):485-92. PubMed ID: 10811540
[TBL] [Abstract][Full Text] [Related]
39. Use of ghrelin in cachexia syndrome: a systematic review of clinical trials.
Mansson JV; Alves FD; Biolo A; Souza GC
Nutr Rev; 2016 Nov; 74(11):659-669. PubMed ID: 27753623
[TBL] [Abstract][Full Text] [Related]
40. A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer.
Currow DC; Glare P; Louw S; Martin P; Clark K; Fazekas B; Agar MR
Sci Rep; 2021 Jan; 11(1):2421. PubMed ID: 33510313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
